Collaborative Transformation

Revolutionizing Healthcare Together

UNEXPECTED PARTNERSHIPS + HEALTHCARE INNOVATION > BUSINESS AS USUAL

×

Today’s healthcare and life sciences worlds are marked by uncommon disruption. But as unexpected partners join forces to innovate in bold and surprising ways, they also face some of healthcare’s toughest challenges. We’re here to help. At McDermott, we believe the power of collaboration will continue to move the industry forward. We call it Collaborative Transformation and our special brand of legal experience, rooted in decades of experience and powered by original thinking, is calibrated to overcome challenges and propel your success. Our renowned health and life sciences experience uniquely positions us to help you thrive in the many types of industry deals taking place throughout the world.

Today’s healthcare and life sciences worlds are marked by uncommon disruption. But as unexpected partners join forces to innovate in bold and surprising ways, they also face some of healthcare’s toughest challenges. We’re here to help. At McDermott, we believe the power of collaboration will continue to move the industry forward. We call it Collaborative Transformation and our special brand of legal experience, rooted in decades of experience and powered by original thinking, is calibrated to overcome challenges and propel your success. Our renowned health and life sciences experience uniquely positions us to help you thrive in the many types of industry deals taking place throughout the world.

FACILITATING CONNECTIONS WITH PURPOSE.

We’re crafters of partnerships who know coming up with the big idea is just the beginning. We get to work, translating inventive thinking into practical solutions and implementation plans. As a result, our clients are already transforming the delivery of healthcare and life sciences solutions.

(CVS + $70B cash and stock) + Aetna = Industry Transformation

×

(CVS + $70B CASH AND STOCK) + AETNA = INDUSTRY TRANSFORMATION

McDermott is one of the firms that has advised CVS Health in connection with its $69 billion purchase of Aetna. The transaction, one of this year's largest M&A deals, is expected to transform the US healthcare sector. Learn More »

Ascension x Centene = MA Plans

×

ASCENSION x CENTENE = MA PLANS

McDermott represented Ascension, the nation’s largest non-profit health system and the world's largest Catholic health system, in its joint venture with health insurer Centene to own and operate Medicare Advantage plans. Through the joint venture MA plans will be established as a preferred model for the respective systems and affiliates for Centene and Ascension in multiple geographic markets beginning in 2020.

The Carle Foundation x University of Illinois = Healthcare Education, Enhanced

×

THE CARLE FOUNDATION x UNIVERSITY OF ILLINOIS = HEALTHCARE EDUCATION, ENHANCED

McDermott advised The Carle Foundation in its unique partnership with the University of Illinois to develop a highly-focused college of medicine, the Carle Illinois College of Medicine. This new medical school will focus on the intersection of engineering and medicine, bringing together respected healthcare and academic systems to help develop future healthcare leaders.

×

(CVS + $70B CASH AND STOCK) + AETNA = INDUSTRY TRANSFORMATION

McDermott is one of the firms that has advised CVS Health in connection with its $69 billion purchase of Aetna. The transaction, one of this year's largest M&A deals, is expected to transform the US healthcare sector. Learn More »

×

ASCENSION x CENTENE = MA PLANS

McDermott represented Ascension, the nation’s largest non-profit health system and the world's largest Catholic health system, in its joint venture with health insurer Centene to own and operate Medicare Advantage plans. Through the joint venture MA plans will be established as a preferred model for the respective systems and affiliates for Centene and Ascension in multiple geographic markets beginning in 2020.

×

THE CARLE FOUNDATION x UNIVERSITY OF ILLINOIS = HEALTHCARE EDUCATION, ENHANCED

McDermott advised The Carle Foundation in its unique partnership with the University of Illinois to develop a highly-focused college of medicine, the Carle Illinois College of Medicine. This new medical school will focus on the intersection of engineering and medicine, bringing together respected healthcare and academic systems to help develop future healthcare leaders.

Read  

The most complex ventures require the most precise attention. Our unmatched health law team can guide you through the transaction. Our regulatory, reimbursement and operational legal experience, coupled with our drive to dig in and roll up our sleeves, drives us to find innovative answers to complex problems and solve the world’s big health issues alongside our clients.

Focus on Innovation Centers

Articles to help activate a culture of transformation across your hospital or health system

Articles

How Hospitals and Health Systems Can Accelerate Innovation
Transformational Healthcare Collaboration Opportunities Emerge from COVID-19 Pandemic
4 Keys to Successful Collaborative Transformations in Healthcare
Industry Voices: How CEOs can compete as nontraditional partnerships reshape healthcare
Collaboration Among Unique Health-Care Providers to Drive Deals in 2019

Watch  

Watch to learn how you can take action to pursue innovation, hear about novel partnerships in action and more

Structuring Healthcare Investments – McDermott’s Innovation Series
McDermott’s Best of JPM 2020

Listen  

We’re always looking at what’s next. Hear how you can transform healthcare and life sciences through unexpected partnerships, unique collaborations and industry-changing deals.

Driving the Deal: Key Payor Changes Affecting Healthcare Private Equity
Driving the Deal: Healthcare Private Equity Opportunities Under the New Administration
Driving the Deal: Public Hospital M&A and Stakeholder Buy-In
Dealmaking in the Sunlight: Navigating Public Hospital M&A
How to Engage in Constructive Disruption
Collaboration Through Innovation Centers
Driving the Deal: FDA Considerations
Driving the Deal: Life Science Partnership Opportunities, Pitfalls, and Impact
Collaborative Transformation Podcast: Driving the Deal

ABOUT THE TEAM

The most complex ventures require the most precise attention. Our unmatched health law team can guide you through the transaction. Our regulatory, reimbursement and operational legal experience, coupled with our drive to dig in and roll up our sleeves, drives us to find innovative answers to complex problems and solve the world’s big health issues alongside our clients.

We understand the need for speed in the health and life sciences landscape. Rather than wait for change to happen, we stand ready at the forefront of innovation. Our cross-practice team offers unmatched legal experience and support to anticipate potential change, quickly adapt, and keep driving you forward, all while balancing regulatory, technological and structural needs. Whether your collaboration is large or small there are several legal considerations, you will need to address – we’re here to help with all the legal aspects of your merger, acquisition, cross-border partnership, joint venture or unique collaboration.

XING


Related Site:     McDermott+ Consulting

Attorney Advertising ©2021 McDermott Will & Emery